Removal of thioridazine from primary care formulary will result in prescribing vacuum.
Wright
N
N
D014150:Antipsychotic Agents / Q000009:adverse effects*; D018492:Dopamine Antagonists / Q000009:adverse effects*; D005569:Formularies as Topic; D006801:Humans; D011320:Primary Health Care; D013881:Thioridazine / Q000009:adverse effects*; D006113:United Kingdom
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D013881:Thioridazine